Products

Kardia 12L and KAI 12L
AliveCor
Cardiology AI
Kardia 12L and KAI 12L offer a portable, AI-powered 12-lead ECG system for healthcare professionals, enabling rapid and accurate detection of numerous cardiac conditions with a simplified setup.
KardiaPro
AliveCor
Cardiology AI
KardiaPro is a comprehensive web-based portal for remote monitoring of patient ECG, blood pressure, and weight data, with FDA-cleared AI for arrhythmia detection and other cardiac determinations. It provides a secure platform to manage and review data between appointments, making it easy for healthcare professionals to analyze trends and make informed clinical decisions for improved patient care.
KardiaAI
AliveCor
Cardiology AI
KardiaAI by AliveCor is an FDA-cleared AI software library for analyzing ambulatory ECG rhythms, detecting various cardiac conditions like AFib, bradycardia, and tachycardia.

See all 6 products →

About AliveCor

AliveCor is a pioneering healthcare AI company specializing in the development of advanced electrocardiogram (ECG) hardware and software solutions for remote heart rhythm monitoring. Their core mission is to transform cardiology by delivering intelligent, highly-personalized heart data to clinicians and patients, aiming to save lives through early detection and management of cardiac conditions.

The company’s product portfolio includes FDA-cleared personal ECG devices like KardiaMobile 6L, which offers instant detection of various arrhythmias such as Atrial Fibrillation (AFib), Bradycardia, and Tachycardia. Most recently, AliveCor launched its AI-powered Kardia 12L ECG System in Europe, following its CE Mark approval. This handheld, portable 12-lead ECG system, featuring a unique single-cable design, leverages KAI 12L AI technology to detect 35 cardiac determinations, including critical conditions like acute myocardial infarction (MI) and common types of cardiac ischemia, significantly streamlining the ECG process for healthcare professionals.

AliveCor’s solutions extend beyond individual consumers to serve healthcare providers, biopharma companies, health systems, employers, and payers, offering comprehensive cardiovascular enterprise services and data integration. Their AI-driven platform is designed to provide medical-grade heart data anytime, anywhere, enhancing clinical decision-making and empowering patients in managing their heart health.

What Physicians Need to Know

Core Specialization
AliveCor specializes in AI-enabled personal electrocardiogram (ECG) devices and cardiac monitoring solutions, aiming to make cardiac monitoring more accessible beyond traditional clinical settings.
Key Differentiators
Their products, such as the newly launched Kardia 12L, are AI-powered, offering the world's first handheld 12-lead ECG with a unique single-cable design. AliveCor's FDA-cleared algorithms can detect up to 35 rhythms and morphologies, providing deeper analysis than simple data recording.
Technology Stack
AliveCor leverages AI-powered algorithms, including multiple deep neural network AI models for ECG interpretation. Their solutions are supported by mobile applications (iOS and Android) and cloud-based platforms like KardiaPro and KardiaStation. They also offer SDK and API solutions for partners to integrate ECG monitoring capabilities and patient data. Cloud and infrastructure components include Amazon AWS, Atlassian Cloud, CloudFlare Hosting, and Cloudflare DNS.
Physician Value Proposition
AliveCor stands out for physicians by providing immediate access to medical-grade ECGs, enabling the detection of a wider range of arrhythmias and cardiac conditions. The ease of use, portability, and comprehensive cardiac insights from their devices, like the Kardia 12L, streamline clinical workflows and support proactive patient management.
Physician Tip

For physicians, AliveCor's solutions offer a powerful tool for remote cardiac monitoring and early detection. The Kardia 12L's portability and AI-driven analysis can provide comprehensive cardiac insights quickly, aiding in the diagnosis and management of various heart conditions. Leveraging their EHR integrations can seamlessly incorporate patient ECG data into existing clinical workflows, enhancing diagnostic confidence and improving patient outcomes.

AliveCor offers robust integration solutions, partnering with leading EHR software and cardiac information management systems, including GE Healthcare's MUSEu2122 NX and Epic's App Orchard Marketplace. They provide EHR Integration, SDK, and API offerings, allowing for the automatic and seamless pulling of patient ECGs into EHR systems, thereby streamlining data access and improving clinical workflow.

Products by AliveCor

6 products in the directory

Kardia 12L and KAI 12L
AliveCor
Cardiology AI
Kardia 12L and KAI 12L offer a portable, AI-powered 12-lead ECG system for healthcare professionals, enabling rapid and accurate detection of numerous cardiac conditions with a simplified setup.
KardiaPro
AliveCor
Cardiology AI
KardiaPro is a comprehensive web-based portal for remote monitoring of patient ECG, blood pressure, and weight data, with FDA-cleared AI for arrhythmia detection and other cardiac determinations. It provides a secure platform to manage and review data between appointments, making it easy for healthcare professionals to analyze trends and make informed clinical decisions for improved patient care.
KardiaAI
AliveCor
Cardiology AI
KardiaAI by AliveCor is an FDA-cleared AI software library for analyzing ambulatory ECG rhythms, detecting various cardiac conditions like AFib, bradycardia, and tachycardia.
Impala
AliveCor
Cardiology AI
AliveCor's 'Impala' (FDA K232035) is a portable, AI-powered 12-Lead ECG device for healthcare professionals, not a physician directory tool. AliveCor specializes in cardiac monitoring solutions.
AliveCor QT Service
AliveCor
Cardiology AI
A cloud-based Software as a Medical Device (SaMD) that provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions.
Corvair
AliveCor
Cardiology AI
Corvair by AliveCor is an FDA-cleared AI ECG analysis system that assists healthcare professionals in interpreting resting diagnostic ECGs with 35 cardiac determinations.

What the Web Says

AliveCor generally receives positive to mixed reviews, particularly for its KardiaMobile products which are praised for their convenience and accuracy in detecting cardiac arrhythmias. However, some users express concerns about subscription models and customer support, while former employees highlight a challenging work environment despite innovative technology.

Overall: Mixed

Strengths

  • Convenient and portable ECG devices (KardiaMobile)
  • Effective in detecting various cardiac arrhythmias (AFib, Bradycardia, Tachycardia)
  • User-friendly app interface and easy to understand results
  • Innovative technology, including AI-powered analysis and 12-lead capabilities
  • Empowers patients to monitor heart health at home
  • Potential to reduce healthcare costs and improve early detection

Limitations

  • Subscription required for full features and detailed reports (KardiaCare)
  • Customer support can be slow or unhelpful for some users
  • Concerns about data privacy and sharing practices
  • Some users find the device inconsistent or inaccurate at times
  • Work-life balance issues and high pressure reported by former employees
  • Perceived as a challenging or demanding work environment by some

Based on reviews from: G2, Glassdoor, Capterra, Reddit, Healthcare IT News, MobiHealthNews, Trustpilot

Last updated: 2026-07-17

Videos

News, demos, and interviews about AliveCor.

Loading videos...

Videos load interactively. If none appear, search YouTube for AliveCor →

View all on YouTube

Press & Coverage

GlobeNewswire
AliveCor Launches AI-Powered Kardia 12L in Europe: The World's First Handheld 12-Lead ECG with a Unique Single-Cable Design
AliveCor announced the CE Mark approval and European launch of its AI-powered Kardia 12L ECG System, a portable 12-lead ECG with a single-cable design for healthcare professionals. This system detects 35 cardiac determinations, including acute myocardial infarction and cardiac ischemia.
2026-04
BioSpace
AliveCor Announces FDA Clearance of New Cardiac Determinations for Kardia 12L ECG System, Bringing Total to 39
AliveCor received FDA clearance for the next generation of its KAI 12L AI technology, which powers the Kardia 12L ECG System, to detect five additional cardiac determinations, bringing the total to 39. This expands the diagnostic capabilities of the handheld 12-lead ECG system.
2026-01
Medical Device and Diagnostic Industry
AliveCor's Tumultuous Week
AliveCor experienced both a major regulatory win with FDA clearance for its Kardia 12L AI technology and a setback in its patent dispute with Apple, where a U.S. federal appeals court ruled in favor of Apple.
2026-01
Medical Product Outsourcing (MPO)
CE Mark Awarded to AliveCor's AI-Powered Kardia 12L Electrocardiogram System
AliveCor's Kardia 12L electrocardiogram system, powered by KAI 12L technology, received CE Mark certification from European regulators. This system is the world's first AI-powered, portable 12-lead ECG with a single-cable design for healthcare professionals.
2026-06
Diagnostic and Interventional Cardiology
Hannover Medical School Integrates GE HealthCare, AliveCor Technologies to Enhance Cardiac Care
Hannover Medical School became the first institution to clinically implement the integration of GE HealthCare's MUSE Cardiology Information System with AliveCor's KardiaMobile 6L ECG device, aiming to optimize patient care through remote monitoring.
2025-11
European Heart Journal - Case Reports
Usefullness of the Kardia AliveCor device to detect acute coronary events: a case report
A case report published in the European Heart Journal - Case Reports highlights the usefulness of the Kardia AliveCor device in detecting acute coronary events, specifically transient ST-segment elevation, which was not captured on a standard ECG.
2025-06
PR Newswire
AliveCor Announces Dual FDA Clearance of AI Technology That Delivers 35 Cardiac Determinations and First-of-its-Kind Kardia 12L ECG System
AliveCor announced dual FDA clearance and commercial launch of its KAI 12L AI technology and the Kardia 12L ECG System, which is the world's first AI-powered handheld 12-lead ECG system with a unique single-cable design capable of detecting life-threatening cardiac conditions.
2024-06
AliveCor
AliveCor Closes $65 Million Financing to Accelerate Growth of Its Remote Cardiology Platform For Consumers, Employers, and Providers
AliveCor announced a $65 million Series E financing round led by existing investors, including OMRON, Khosla Ventures, and Qualcomm Ventures, to accelerate the growth of its remote cardiology platform globally.
2020-11

Frequently Asked Questions

AliveCor offers AI-powered ECG devices such as KardiaMobile, KardiaMobile 6L, and the Kardia 12L ECG System, which is the world's first AI-powered handheld 12-lead ECG. These devices, coupled with the KardiaPro platform, provide medical-grade heart data and AI-driven interpretations for a comprehensive range of arrhythmias and cardiac conditions, including atrial fibrillation.
AliveCor's AI algorithms are FDA-cleared and extensively clinically validated, utilizing advanced deep neural networks and machine learning techniques. Studies have demonstrated high sensitivity and specificity for detecting various cardiac conditions, such as Atrial Fibrillation, ensuring reliable diagnostic support for clinicians.
AliveCor holds multiple U.S. Food and Drug Administration (FDA) clearances for its devices and AI algorithms, including for KardiaMobile, KardiaMobile 6L, and the Kardia 12L ECG System. These clearances cover the detection of numerous cardiac determinations, such as atrial fibrillation, bradycardia, tachycardia, and other arrhythmias.
While specific institutional pricing models are not always publicly detailed, AliveCor provides solutions for health systems and providers that include reimbursable options and access to their physician portal, KardiaPro. For patients, a KardiaCare subscription is available for $9.99 per month or $99 per year, which includes features like board-certified cardiologist reviews.
AliveCor offers a physician portal, KardiaPro, for seamless remote patient management and ECG data review. Additionally, AliveCor Labs functions as an independent diagnostic testing facility, providing 24/7 monitoring, real-time analysis, and reporting by certified technicians. For patients, the KardiaCare subscription enhances support with advanced insights and access to board-certified cardiologist reviews.
Yes, AliveCor integrates with existing EHR systems through partnerships with leading EHR software and cardiac information management systems, such as GE Healthcare's MUSE Cardiac Management System and Epic's App Orchard Marketplace. This allows for the automatic and seamless integration of ECG data into patient records and clinical workflows. AliveCor also offers SDK and API solutions for broader integration.
AliveCor is committed to patient data privacy and ensures its Kardia and KardiaPro platforms are HIPAA compliant, adhering to the Security Rule and Breach Notification Rule. The company also holds several key certifications, including ISO 42001 for Artificial Intelligence Management System, ISO 27001, HITRUST e1, and SOC 2 Type 2, demonstrating robust security and privacy practices.

Investors

Who's funded AliveCor.

Related Companies

Intelligent Voice AI (IVAI) is an agentic AI platform that deploys AI voice agents specifically designed for healthcare, insurance, legal, and home services businesses. For physicians and medical practices, IVAI’s Evolve AI Agents act as an AI workforce, not just an answering service, handling a comprehensive range of administrative and operational tasks. These agents can […]

Dext, formerly known as Receipt Bank, is a company that specializes in bookkeeping automation, leveraging data, technology, and applied AI to enhance productivity and efficiency for businesses, accountants, and bookkeepers. [3, 16] Their platform is designed to streamline financial document management and automate bookkeeping tasks, aiming to simplify the accounting process and enable more informed […]

Cortex (https://www.cortex.app) is an AI-powered internal developer portal designed to enhance engineering excellence and streamline software development workflows. For physicians, this translates to a platform that can indirectly improve healthcare technology by enabling engineering teams to build more reliable, secure, and efficient software. The platform helps in cataloging, scoring, and assigning actions to improve service […]

Nino is an AI-powered financial planning and tax service that aims to provide comprehensive financial guidance. For physicians, Nino’s AI software can help manage income, student loans, and plan career transitions, such as moving from training to practice or considering practice ownership. The platform allows physicians to view loans, income, and savings in one place, […]

Coral AI is a healthcare artificial intelligence company that aims to streamline administrative workflows for healthcare providers, ultimately accelerating patient access to care. The company’s AI-driven platform integrates with existing healthcare systems, including EHRs, fax lines, and payer portals, to automate complex administrative tasks. This includes patient intake, prior authorizations, billing, compliance, and patient outreach. […]

SamaCare is a healthcare AI company that provides a cloud-based workflow intelligence platform designed to streamline the prior authorization process for specialty medications. The company’s platform aims to reduce the administrative burden on medical practices, improve approval rates, and add predictability to patient care. By digitizing the often manual and paper-heavy prior authorization process, SamaCare […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.